Financials data is unavailable for this security.
View more
Year on year Sanofi SA grew revenues 5.49% from 44.29bn to 46.72bn while net income improved 40.52% from 5.56bn to 7.81bn.
| Gross margin | -- |
|---|---|
| Net profit margin | -- |
| Operating margin | -- |
| Return on assets | -- |
|---|---|
| Return on equity | -- |
| Return on investment | -- |
More ▼
Cash flow in EURView more
In 2025, Sanofi SA did not generate a significant amount of cash. However, the company earned 10.92bn from its operations for a Cash Flow Margin of 23.37%. In addition the company used 2.45bn on investing activities and also paid 8.21bn in financing cash flows.
| Cash flow per share | -- |
|---|---|
| Price/Cash flow per share | -- |
| Book value per share | 59.04 |
|---|---|
| Tangible book value per share | 3.16 |
More ▼
Balance sheet in EURView more
| Current ratio | 1.09 |
|---|---|
| Quick ratio | -- |
| Total debt/total equity | 0.2848 |
|---|---|
| Total debt/total capital | 0.2209 |
More ▼
Growth rates in EUR
SmartText is unavailable
| Div yield(5 year avg) | 4.20% |
|---|---|
| Div growth rate (5 year) | 5.18% |
| Payout ratio (TTM) | -- |
| EPS growth(5 years) | -16.14 |
|---|---|
| EPS (TTM) vs TTM 1 year ago | -- |
More ▼
